Mechanisms of thrombosis in ANCA-associated vasculitis.

Clinical Rheumatology
Durga Prasanna MisraOlena Zimba

Abstract

Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a two- to threefold greater risk of developing venous as well as arterial thrombotic events. Although such thrombotic events are more commonly seen during phases of active AAV, they are also recognized to occur during AAV in remission. Endothelial injury is a key pathogenic event in AAV. Endothelial injury can be caused by neutrophil activation and release of thrombogenic tissue factor into the circulation. Neutrophil activation further results in the formation of neutrophil extracellular traps (NETs). NETs contribute to thrombosis by expressing tissue factor. NETs have also been detected in cutaneous thrombi from patients with AAV induced by hydralazine. Activated neutrophils in AAV patients release thrombogenic microparticles loaded with tissue factor which further enhances clotting of blood. Antiphospholipid antibodies (APLs) have been detected in up to a third of AAV and might also be induced by drugs such as cocaine adulterated with levamisole and propylthiouracil, which are known to trigger AAV. Such APLs further drive the thrombosis in AAV. Once thrombogenesis occurs, the homeostatic mechanisms resulting in clot dissolution are fur...Continue Reading

References

Apr 1, 1984·American Journal of Hematology·S I Chavin
Oct 31, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G WolfR A Stahl
Nov 8, 2002·Archives of Pathology & Laboratory Medicine·John T Brandt
May 10, 2005·Postgraduate Medical Journal·P D GaburriA K Gaburri
Feb 8, 2006·Arthritis and Rheumatism·Sven WeidnerHarald D Rupprecht
Aug 15, 2008·Journal of the American Society of Nephrology : JASN·David J BautzRonald J Falk
May 19, 2009·Nature Medicine·Kai KessenbrockDieter E Jenne
Jul 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Saulius ButenasKenneth G Mann
Jul 30, 2011·Rheumatology International·Armen Yuri GasparyanGeorge D Kitas
Oct 10, 2012·Arthritis and Rheumatism·J C JennetteR A Watts
Nov 20, 2012·Frontiers in Immunology·Daigo NakazawaAkihiro Ishizu
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·T Nightingale, D Cutler
Oct 17, 2013·The Journal of Rheumatology·Marc HilhorstJan Willem Cohen Tervaert
Jan 5, 2014·Journal of the American Society of Nephrology : JASN·Daigo NakazawaAkihiro Ishizu
Nov 9, 2014·Annals of the Rheumatic Diseases·Pavel NovikovLeonid Strizhakov
Dec 20, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anna SalmelaRiitta Lassila
Sep 26, 2015·Rheumatology International·Durga Prasanna Misra, Vikas Agarwal
Nov 26, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Alan E Mast
Feb 18, 2016·Rheumatology International·Durga Prasanna Misra, Sajjan N Shenoy
Apr 28, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·F V VeroneseE J G Barros
May 25, 2016·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Aaron W PumerantzChristopher L Tracy
Jun 17, 2016·International Journal of Critical Illness and Injury Science·Hasan F Al-AzzawiMingchen Song
Oct 18, 2016·European Journal of Dermatology : EJD·Cynthia M MagroJoanna Harp
Oct 3, 2013·Open Access Rheumatology : Research and Reviews·Miraida Reneé García PérezRogelio Mercado
Jan 6, 2017·Rheumatology·Andreas KronbichlerUNKNOWN European Vasculitis Society
Feb 24, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Sravya KattulaAlisa S Wolberg
Apr 30, 2017·Frontiers in Immunology·Rachita PandaTobias A Fuchs
Sep 1, 2018·International Journal of Rheumatic Diseases·Durga P MisraAman Sharma
Nov 1, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Hao ChenLiguo Dong
Dec 14, 2018·Nature Reviews. Rheumatology·Daigo NakazawaAkihiro Ishizu
Feb 26, 2019·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Juyoung YooSang-Won Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.